CAS NO: | 2762617-31-0 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | YAP/TAZ inhibitor-2 is a potent and orally activeTEAD-YAP/TAZinhibitor with anEC50value of 3 nM. YAP/TAZ inhibitor-2 shows anti-proliferative activity. YAP/TAZ inhibitor-2 shows antitumor activity[1]. | ||||||||||||||||
IC50& Target | EC50: 3 nM (TEAD-YAP/TAZ)[1] | ||||||||||||||||
体外研究 (In Vitro) | YAP/TAZ inhibitor-2 (compound 5) (0-20000 nM; 24 h) shows antiproliferative activity with an IC50value of 5.33 nM in NCI-H226 cells[1]. | ||||||||||||||||
体内研究 (In Vivo) | YAP/TAZ inhibitor-2 (0.5, 2, 5, 50 mg/kg; p.o.; daily for 28 days) shows anti-tumor activity with no significant body weight loss during the treatment in BALB/c nude mice (NCI-H226 xenograft model)[1]. | ||||||||||||||||
分子量 | 390.33 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H14F4N4O | ||||||||||||||||
CAS 号 | 2762617-31-0 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(256.19 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |